| Year |
Citation |
Score |
| 2019 |
Soda T, McLoughlin DM, Clark SR, Oltedal L, Kessler U, Haavik J, Bousman C, Smith DJ, Bioque M, Clements CC, Loo C, Vila-Rodriguez F, Minelli A, Mickey BJ, Milev R, et al. International Consortium on the Genetics of Electroconvulsive Therapy and Severe Depressive Disorders (Gen-ECT-ic). European Archives of Psychiatry and Clinical Neuroscience. PMID 31802253 DOI: 10.1007/S00406-019-01087-W |
0.31 |
|
| 2019 |
Ryan KM, Poelz L, McLoughlin DM. Low Circulating Levels of GR, FKBP5, and SGK1 in Medicated Patients With Depression Are Not Altered by Electroconvulsive Therapy. The Journal of Ect. PMID 31725056 DOI: 10.1097/Yct.0000000000000633 |
0.324 |
|
| 2019 |
Ryan KM, Allers KA, McLoughlin DM, Harkin A. Tryptophan metabolite concentrations in depressed patients before and after electroconvulsive therapy. Brain, Behavior, and Immunity. PMID 31606477 DOI: 10.1016/J.Bbi.2019.10.005 |
0.313 |
|
| 2019 |
Ryan KM, McLoughlin DM. Telomere length in depression and association with therapeutic response to electroconvulsive therapy and cognitive side-effects. Psychological Medicine. 1-11. PMID 31477194 DOI: 10.1017/S0033291719002228 |
0.324 |
|
| 2018 |
Ryan KM, McLoughlin DM. Peripheral blood GILZ mRNA levels in depression and following electroconvulsive therapy. Psychoneuroendocrinology. 101: 304-310. PMID 30602137 DOI: 10.1016/J.Psyneuen.2018.12.234 |
0.334 |
|
| 2018 |
Finnegan M, Galligan T, Ryan K, Shanahan E, Harkin A, Daly L, McLoughlin DM. Ketamine Versus Midazolam for Depression Relapse Prevention Following Successful Electroconvulsive Therapy: A Randomized Controlled Pilot Trial. The Journal of Ect. PMID 30531397 DOI: 10.1097/Yct.0000000000000560 |
0.308 |
|
| 2018 |
McGrory CL, Ryan KM, Kolshus E, McLoughlin DM. Peripheral blood E2F1 mRNA in depression and following electroconvulsive therapy. Progress in Neuro-Psychopharmacology & Biological Psychiatry. PMID 30365982 DOI: 10.1016/J.Pnpbp.2018.10.011 |
0.319 |
|
| 2018 |
McGrory CL, Ryan KM, Kolshus E, Finnegan M, McLoughlin DM. Peripheral blood SIRT1 mRNA levels in depression and treatment with electroconvulsive therapy. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. PMID 30017261 DOI: 10.1016/J.Euroneuro.2018.06.007 |
0.329 |
|
| 2018 |
Ryan KM, McLoughlin DM. Vascular endothelial growth factor plasma levels in depression and following electroconvulsive therapy. European Archives of Psychiatry and Clinical Neuroscience. PMID 29968119 DOI: 10.1007/S00406-018-0919-X |
0.321 |
|
| 2018 |
Allen AP, Naughton M, Dowling J, Walsh A, O'Shea R, Shorten G, Scott L, McLoughlin DM, Cryan JF, Clarke G, Dinan TG. Kynurenine pathway metabolism and the neurobiology of treatment-resistant depression: Comparison of multiple ketamine infusions and electroconvulsive therapy. Journal of Psychiatric Research. 100: 24-32. PMID 29475018 DOI: 10.1016/J.Jpsychires.2018.02.011 |
0.315 |
|
| 2017 |
Kolshus E, Ryan KM, Blackshields G, Smyth P, Sheils O, McLoughlin DM. Peripheral blood microRNA and VEGFA mRNA changes following electroconvulsive therapy: implications for psychotic depression. Acta Psychiatrica Scandinavica. PMID 28975998 DOI: 10.1111/Acps.12821 |
0.302 |
|
| 2017 |
Ryan KM, Glaviano A, O'Donovan SM, Kolshus E, Dunne R, Kavanagh A, Jelovac A, Noone M, Tucker GM, Dunn MJ, McLoughlin DM. Electroconvulsive therapy modulates plasma pigment epithelium-derived factor in depression: a proteomics study. Translational Psychiatry. 7: e1073. PMID 28350398 DOI: 10.1038/Tp.2017.51 |
0.352 |
|
| 2016 |
Finnegan M, Ryan K, Shanahan E, Harkin A, Daly L, McLoughlin DM. Ketamine for depression relapse prevention following electroconvulsive therapy: protocol for a randomised pilot trial (the KEEP-WELL trial). Pilot and Feasibility Studies. 2: 38. PMID 27965856 DOI: 10.1186/S40814-016-0080-0 |
0.328 |
|
| 2016 |
Gururajan A, Naughton ME, Scott KA, O'Connor RM, Moloney G, Clarke G, Dowling J, Walsh A, Ismail F, Shorten G, Scott L, McLoughlin DM, Cryan JF, Dinan TG. MicroRNAs as biomarkers for major depression: a role for let-7b and let-7c. Translational Psychiatry. 6: e862. PMID 27483380 DOI: 10.1038/Tp.2016.131 |
0.302 |
|
| 2016 |
Semkovska M, Landau S, Dunne R, Kolshus E, Kavanagh A, Jelovac A, Noone M, Carton M, Lambe S, McHugh C, McLoughlin DM. Bitemporal Versus High-Dose Unilateral Twice-Weekly Electroconvulsive Therapy for Depression (EFFECT-Dep): A Pragmatic, Randomized, Non-Inferiority Trial. The American Journal of Psychiatry. appiajp201515030372. PMID 26892939 DOI: 10.1176/Appi.Ajp.2015.15030372 |
0.301 |
|
| 2016 |
Finnegan M, McLoughlin D. Neurostimulatory, neuromodulatory and neurosurgical treatments in psychiatry Medicine. 44: 742-744. DOI: 10.1016/J.Mpmed.2016.09.009 |
0.319 |
|
| 2015 |
Allen AP, Naughton M, Dowling J, Walsh A, Ismail F, Shorten G, Scott L, McLoughlin DM, Cryan JF, Dinan TG, Clarke G. Serum BDNF as a peripheral biomarker of treatment-resistant depression and the rapid antidepressant response: A comparison of ketamine and ECT. Journal of Affective Disorders. 186: 306-311. PMID 26275358 DOI: 10.1016/J.Jad.2015.06.033 |
0.3 |
|
| 2015 |
Jelovac A, OʼConnor S, McCarron S, McLoughlin DM. Autobiographical Memory Specificity in Major Depression Treated With Electroconvulsive Therapy. The Journal of Ect. PMID 26252557 DOI: 10.1097/Yct.0000000000000267 |
0.311 |
|
| 2015 |
Semkovska M, Lambe S, Lonargáin DÓ, McLoughlin DM. Neurocognitive Remediation Therapy for Depression: A Feasibility Study and Randomized Controlled Pilot Protocol Testing. The Journal of Nervous and Mental Disease. 203: 609-16. PMID 26153888 DOI: 10.1097/Nmd.0000000000000337 |
0.324 |
|
| 2014 |
O'Donovan SM, O'Mara S, Dunn MJ, McLoughlin DM. The persisting effects of electroconvulsive stimulation on the hippocampal proteome. Brain Research. 1593: 106-16. PMID 25451099 DOI: 10.1016/J.Brainres.2014.10.020 |
0.313 |
|
| 2014 |
O'Donovan S, Dalton V, Harkin A, McLoughlin DM. Effects of brief pulse and ultrabrief pulse electroconvulsive stimulation on rodent brain and behaviour in the corticosterone model of depression. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 17: 1477-86. PMID 24607259 DOI: 10.1017/S1461145714000200 |
0.311 |
|
| 2013 |
Thekiso TB, Heron EA, Masood B, Murphy M, McLoughlin DM, Kennedy N. Mauling of the "Celtic Tiger": clinical characteristics and outcome of first-episode depression secondary to the economic recession in Ireland. Journal of Affective Disorders. 151: 455-60. PMID 23948630 DOI: 10.1016/J.Jad.2013.06.024 |
0.32 |
|
| 2013 |
Semkovska M, McLoughlin DM. Measuring retrograde autobiographical amnesia following electroconvulsive therapy: historical perspective and current issues. The Journal of Ect. 29: 127-33. PMID 23303426 DOI: 10.1097/Yct.0B013E318279C2C9 |
0.3 |
|
| 2013 |
Agyapong V, McLoughlin D, Farren C. 581 – 6-month outcomes of a single blind randomised trial of supportive text messaging for depression and comorbid alcohol use disorder European Psychiatry. 28: 1. DOI: 10.1016/S0924-9338(13)75859-0 |
0.301 |
|
| 2013 |
Ryan K, Harkin A, McLoughlin D. 116. The hippocampal miRNome in the chronic corticosterone model of depression Brain, Behavior, and Immunity. 32: e33-e34. DOI: 10.1016/J.Bbi.2013.07.128 |
0.32 |
|
| 2012 |
Hughes MM, Carballedo A, McLoughlin DM, Amico F, Harkin A, Frodl T, Connor TJ. Tryptophan depletion in depressed patients occurs independent of kynurenine pathway activation. Brain, Behavior, and Immunity. 26: 979-87. PMID 22683764 DOI: 10.1016/J.Bbi.2012.05.010 |
0.307 |
|
| 2012 |
Agyapong VI, Ahern S, McLoughlin DM, Farren CK. Supportive text messaging for depression and comorbid alcohol use disorder: single-blind randomised trial. Journal of Affective Disorders. 141: 168-76. PMID 22464008 DOI: 10.1016/J.Jad.2012.02.040 |
0.312 |
|
| 2012 |
Semkovska M, Noone M, Carton M, McLoughlin DM. Measuring consistency of autobiographical memory recall in depression. Psychiatry Research. 197: 41-8. PMID 22397910 DOI: 10.1016/J.Psychres.2011.12.010 |
0.305 |
|
| 2012 |
Hao Y, Chai KH, McLoughlin DM, Chan HY, Lau KF. Promoter characterization and genomic organization of the human X11β gene APBA2. Neuroreport. 23: 146-51. PMID 22222501 DOI: 10.1097/Wnr.0B013E32834F1934 |
0.311 |
|
| 2012 |
Chai KH, McLoughlin DM, Chan TF, Chan HY, Lau KF. Genomic organization and promoter cloning of the human X11α gene APBA1. Dna and Cell Biology. 31: 651-9. PMID 22136355 DOI: 10.1089/Dna.2011.1447 |
0.321 |
|
| 2012 |
Manser C, Guillot F, Vagnoni A, Davies J, Lau KF, McLoughlin DM, De Vos KJ, Miller CC. Lemur tyrosine kinase-2 signalling regulates kinesin-1 light chain-2 phosphorylation and binding of Smad2 cargo. Oncogene. 31: 2773-82. PMID 21996745 DOI: 10.1038/Onc.2011.437 |
0.446 |
|
| 2012 |
Semkovska M, O’Lonargain D, Lambe S, McLoughlin D. P-1190 - Neurocognitive remediation for depression: a feasibility study European Psychiatry. 27: 1. DOI: 10.1016/S0924-9338(12)75357-9 |
0.328 |
|
| 2010 |
Lau KF, Perkinton MS, Rodriguez L, McLoughlin DM, Miller CC. An X11alpha/FSBP complex represses transcription of the GSK3beta gene promoter. Neuroreport. 21: 761-6. PMID 20531236 DOI: 10.1097/Wnr.0B013E32833Bfca0 |
0.51 |
|
| 2010 |
Mitchell JC, Perkinton MS, Yates DM, Lau KF, Rogelj B, Miller CC, McLoughlin DM. Expression of the neuronal adaptor protein X11alpha protects against memory dysfunction in a transgenic mouse model of Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 20: 31-6. PMID 20378958 DOI: 10.3233/Jad-2009-1341 |
0.488 |
|
| 2010 |
Tudor EL, Galtrey CM, Perkinton MS, Lau KF, De Vos KJ, Mitchell JC, Ackerley S, Hortobágyi T, Vámos E, Leigh PN, Klasen C, McLoughlin DM, Shaw CE, Miller CC. Amyotrophic lateral sclerosis mutant vesicle-associated membrane protein-associated protein-B transgenic mice develop TAR-DNA-binding protein-43 pathology. Neuroscience. 167: 774-85. PMID 20188146 DOI: 10.1016/J.Neuroscience.2010.02.035 |
0.471 |
|
| 2010 |
Yu HT, Chan WW, Chai KH, Lee CW, Chang RC, Yu MS, McLoughlin DM, Miller CC, Lau KF. Transcriptional regulation of human FE65, a ligand of Alzheimer's disease amyloid precursor protein, by Sp1. Journal of Cellular Biochemistry. 109: 782-93. PMID 20091743 DOI: 10.1002/Jcb.22457 |
0.482 |
|
| 2009 |
Mitchell JC, Ariff BB, Yates DM, Lau KF, Perkinton MS, Rogelj B, Stephenson JD, Miller CC, McLoughlin DM. X11beta rescues memory and long-term potentiation deficits in Alzheimer's disease APPswe Tg2576 mice. Human Molecular Genetics. 18: 4492-500. PMID 19744962 DOI: 10.1093/Hmg/Ddp408 |
0.507 |
|
| 2009 |
Stevenson A, Yates DM, Manser C, De Vos KJ, Vagnoni A, Leigh PN, McLoughlin DM, Miller CC. Riluzole protects against glutamate-induced slowing of neurofilament axonal transport. Neuroscience Letters. 454: 161-4. PMID 19429076 DOI: 10.1016/J.Neulet.2009.02.061 |
0.431 |
|
| 2009 |
Yates DM, Manser C, De Vos KJ, Shaw CE, McLoughlin DM, Miller CC. Neurofilament subunit (NFL) head domain phosphorylation regulates axonal transport of neurofilaments. European Journal of Cell Biology. 88: 193-202. PMID 19147253 DOI: 10.1016/J.Ejcb.2008.11.004 |
0.439 |
|
| 2008 |
Lau KF, Chan WM, Perkinton MS, Tudor EL, Chang RC, Chan HY, McLoughlin DM, Miller CC. Dexras1 interacts with FE65 to regulate FE65-amyloid precursor protein-dependent transcription. The Journal of Biological Chemistry. 283: 34728-37. PMID 18922798 DOI: 10.1074/Jbc.M801874200 |
0.48 |
|
| 2008 |
Manser C, Stevenson A, Banner S, Davies J, Tudor EL, Ono Y, Leigh PN, McLoughlin DM, Shaw CE, Miller CC. Deregulation of PKN1 activity disrupts neurofilament organisation and axonal transport. Febs Letters. 582: 2303-8. PMID 18519042 DOI: 10.1016/J.Febslet.2008.05.034 |
0.437 |
|
| 2008 |
Mogg A, Pluck G, Eranti SV, Landau S, Purvis R, Brown RG, Curtis V, Howard R, Philpot M, McLoughlin DM. A randomized controlled trial with 4-month follow-up of adjunctive repetitive transcranial magnetic stimulation of the left prefrontal cortex for depression. Psychological Medicine. 38: 323-33. PMID 17935639 DOI: 10.1017/S0033291707001663 |
0.311 |
|
| 2008 |
McLoughlin DM, Miller CC. The FE65 proteins and Alzheimer's disease. Journal of Neuroscience Research. 86: 744-54. PMID 17828772 DOI: 10.1002/Jnr.21532 |
0.496 |
|
| 2008 |
Yates D, McLoughlin DM. The molecular pathology of Alzheimer's disease Psychiatry. 7: 1-5. DOI: 10.1016/J.Mppsy.2007.11.009 |
0.333 |
|
| 2008 |
Yates DM, Mitchell JC, Ariff B, Stephenson J, Miller CC, McLoughlin DM. P1-058: The neuronal X11α adaptor protein improves cognitive function of Tg2576 (APPswe) mice Alzheimer's & Dementia. 4: T222-T223. DOI: 10.1016/J.Jalz.2008.05.644 |
0.471 |
|
| 2008 |
Mitchell JC, Yates DM, Ariff B, Stephenson J, Miller CC, McLoughlin DM. O4-02-04: The neuronal X11β adaptor protein improves cognitive and neuronal function in Tg2576 (APPswe) mice Alzheimer's & Dementia. 4: T187-T187. DOI: 10.1016/J.Jalz.2008.05.512 |
0.458 |
|
| 2007 |
De Vos KJ, Chapman AL, Tennant ME, Manser C, Tudor EL, Lau KF, Brownlees J, Ackerley S, Shaw PJ, McLoughlin DM, Shaw CE, Leigh PN, Miller CC, Grierson AJ. Familial amyotrophic lateral sclerosis-linked SOD1 mutants perturb fast axonal transport to reduce axonal mitochondria content. Human Molecular Genetics. 16: 2720-8. PMID 17725983 DOI: 10.1093/Hmg/Ddm226 |
0.444 |
|
| 2007 |
Eranti S, Mogg A, Pluck G, Landau S, Purvis R, Brown RG, Howard R, Knapp M, Philpot M, Rabe-Hesketh S, Romeo R, Rothwell J, Edwards D, McLoughlin DM. A randomized, controlled trial with 6-month follow-up of repetitive transcranial magnetic stimulation and electroconvulsive therapy for severe depression. The American Journal of Psychiatry. 164: 73-81. PMID 17202547 DOI: 10.1176/Appi.Ajp.164.1.73 |
0.308 |
|
| 2006 |
Rogelj B, Mitchell JC, Miller CC, McLoughlin DM. The X11/Mint family of adaptor proteins. Brain Research Reviews. 52: 305-15. PMID 16764936 DOI: 10.1016/J.Brainresrev.2006.04.005 |
0.496 |
|
| 2006 |
Miller CC, McLoughlin DM, Lau KF, Tennant ME, Rogelj B. The X11 proteins, Abeta production and Alzheimer's disease. Trends in Neurosciences. 29: 280-5. PMID 16545469 DOI: 10.1016/J.Tins.2006.03.001 |
0.491 |
|
| 2006 |
Mitchell JC, Rogelj B, Ariff B, Sluyter F, Stephenson J, Miller CC, McLoughlin DM. P1-054: The neuronal X11α adaptor protein improves cognitive function of Tg2576 (APPswe) mice Alzheimer's & Dementia. 2: S110-S110. DOI: 10.1016/J.Jalz.2006.05.429 |
0.471 |
|
| 2005 |
Tudor EL, Perkinton MS, Schmidt A, Ackerley S, Brownlees J, Jacobsen NJ, Byers HL, Ward M, Hall A, Leigh PN, Shaw CE, McLoughlin DM, Miller CC. ALS2/Alsin regulates Rac-PAK signaling and neurite outgrowth. The Journal of Biological Chemistry. 280: 34735-40. PMID 16049005 DOI: 10.1074/Jbc.M506216200 |
0.461 |
|
| 2004 |
Lee JH, Lau KF, Perkinton MS, Standen CL, Rogelj B, Falinska A, McLoughlin DM, Miller CC. The neuronal adaptor protein X11beta reduces amyloid beta-protein levels and amyloid plaque formation in the brains of transgenic mice. The Journal of Biological Chemistry. 279: 49099-104. PMID 15347685 DOI: 10.1074/Jbc.M405602200 |
0.64 |
|
| 2004 |
Perkinton MS, Standen CL, Lau KF, Kesavapany S, Byers HL, Ward M, McLoughlin DM, Miller CC. The c-Abl tyrosine kinase phosphorylates the Fe65 adaptor protein to stimulate Fe65/amyloid precursor protein nuclear signaling. The Journal of Biological Chemistry. 279: 22084-91. PMID 15031292 DOI: 10.1074/Jbc.M311479200 |
0.488 |
|
| 2004 |
McLoughlin DM, Lee J, Lau K, Perkinton MS, Cooper JD, Miller CC. P2-083 The X11α and X11β neuronal adaptor proteins reduce Aβ levels and deposition in TG2576 mice Neurobiology of Aging. 25: S247. DOI: 10.1016/S0197-4580(04)80830-3 |
0.312 |
|
| 2004 |
Miller C, McLoughlin D, Perkinton MS, Lau K. P1-269 FE65 and X11alpha in nuclear signalling Neurobiology of Aging. 25: S172-S173. DOI: 10.1016/S0197-4580(04)80582-7 |
0.432 |
|
| 2003 |
Standen CL, Perkinton MS, Byers HL, Kesavapany S, Lau KF, Ward M, McLoughlin D, Miller CC. The neuronal adaptor protein Fe65 is phosphorylated by mitogen-activated protein kinase (ERK1/2). Molecular and Cellular Neurosciences. 24: 851-7. PMID 14697653 DOI: 10.1016/J.Mcn.2003.07.002 |
0.477 |
|
| 2003 |
Lee JH, Lau KF, Perkinton MS, Standen CL, Shemilt SJ, Mercken L, Cooper JD, McLoughlin DM, Miller CC. The neuronal adaptor protein X11alpha reduces Abeta levels in the brains of Alzheimer's APPswe Tg2576 transgenic mice. The Journal of Biological Chemistry. 278: 47025-9. PMID 12970358 DOI: 10.1074/Jbc.M300503200 |
0.627 |
|
| 2003 |
Kesavapany S, Lau KF, Ackerley S, Banner SJ, Shemilt SJ, Cooper JD, Leigh PN, Shaw CE, McLoughlin DM, Miller CC. Identification of a novel, membrane-associated neuronal kinase, cyclin-dependent kinase 5/p35-regulated kinase. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 23: 4975-83. PMID 12832520 DOI: 10.1523/Jneurosci.23-12-04975.2003 |
0.467 |
|
| 2002 |
Kesavapany S, Banner SJ, Lau KF, Shaw CE, Miller CC, Cooper JD, McLoughlin DM. Expression of the Fe65 adapter protein in adult and developing mouse brain. Neuroscience. 115: 951-60. PMID 12435432 DOI: 10.1016/S0306-4522(02)00422-0 |
0.49 |
|
| 2002 |
Lau KF, Howlett DR, Kesavapany S, Standen CL, Dingwall C, McLoughlin DM, Miller CC. Cyclin-dependent kinase-5/p35 phosphorylates Presenilin 1 to regulate carboxy-terminal fragment stability. Molecular and Cellular Neurosciences. 20: 13-20. PMID 12056836 DOI: 10.1006/Mcne.2002.1108 |
0.458 |
|
| 2002 |
Lovestone S, McLoughlin DM. Protein aggregates and dementia: is there a common toxicity? Journal of Neurology, Neurosurgery, and Psychiatry. 72: 152-61. PMID 11796764 DOI: 10.1136/Jnnp.72.2.152 |
0.316 |
|
| 2001 |
Kesavapany S, Lau KF, McLoughlin DM, Brownlees J, Ackerley S, Leigh PN, Shaw CE, Miller CC. p35/cdk5 binds and phosphorylates beta-catenin and regulates beta-catenin/presenilin-1 interaction. The European Journal of Neuroscience. 13: 241-7. PMID 11168528 DOI: 10.1046/J.1460-9568.2001.01376.X |
0.453 |
|
| 2001 |
Standen CL, Brownlees J, Grierson AJ, Kesavapany S, Lau KF, McLoughlin DM, Miller CC. Phosphorylation of thr(668) in the cytoplasmic domain of the Alzheimer's disease amyloid precursor protein by stress-activated protein kinase 1b (Jun N-terminal kinase-3). Journal of Neurochemistry. 76: 316-20. PMID 11146006 DOI: 10.1046/J.1471-4159.2001.00102.X |
0.48 |
|
| 2001 |
McLoughlin DM, Standen CL, Lau KF, Ackerley S, Bartnikas TP, Gitlin JD, Miller CC. The neuronal adaptor protein X11alpha interacts with the copper chaperone for SOD1 and regulates SOD1 activity. The Journal of Biological Chemistry. 276: 9303-7. PMID 11115513 DOI: 10.1074/Jbc.M010023200 |
0.478 |
|
| 2000 |
Lau KF, McLoughlin DM, Standen CL, Irving NG, Miller CC. Fe65 and X11beta co-localize with and compete for binding to the amyloid precursor protein. Neuroreport. 11: 3607-10. PMID 11095528 DOI: 10.1097/00001756-200011090-00041 |
0.489 |
|
| 2000 |
Lau KF, McLoughlin DM, Standen C, Miller CC. X11 alpha and x11 beta interact with presenilin-1 via their PDZ domains. Molecular and Cellular Neurosciences. 16: 557-65. PMID 11083918 DOI: 10.1006/Mcne.2000.0898 |
0.448 |
|
| 2000 |
McLoughlin D, Lau K, Irving N, Standen C, Brion J, Miller C. THE XI1 AND FE65 PROTEINS IN ALZHEIMER'S DISEASE Biochemical Society Transactions. 28: A37-A37. DOI: 10.1042/Bst028A037C |
0.478 |
|
| 1999 |
McLoughlin DM, Irving NG, Brownlees J, Brion JP, Leroy K, Miller CC. Mint2/X11-like colocalizes with the Alzheimer's disease amyloid precursor protein and is associated with neuritic plaques in Alzheimer's disease. The European Journal of Neuroscience. 11: 1988-94. PMID 10336668 DOI: 10.1046/J.1460-9568.1999.00610.X |
0.502 |
|
| 1998 |
McLoughlin DM, Irving NG, Miller CC. The Fe65 and X11 families of proteins: proteins that interact with the Alzheimer's disease amyloid precursor protein. Biochemical Society Transactions. 26: 497-500. PMID 9765903 DOI: 10.1042/Bst0260497 |
0.489 |
|
| 1998 |
Blanco G, Irving NG, Brown SD, Miller CC, McLoughlin DM. Mapping of the human and murine X11-like genes (APBA2 and apba2), the murine Fe65 gene (Apbb1), and the human Fe65-like gene (APBB2): genes encoding phosphotyrosine-binding domain proteins that interact with the Alzheimer's disease amyloid precursor protein. Mammalian Genome : Official Journal of the International Mammalian Genome Society. 9: 473-5. PMID 9585438 DOI: 10.1007/S003359900800 |
0.472 |
|
| 1998 |
Guidato S, McLoughlin DM, Grierson AJ, Miller CC. Cyclin D2 interacts with cdk-5 and modulates cellular cdk-5/p35 activity. Journal of Neurochemistry. 70: 335-40. PMID 9422379 DOI: 10.1046/J.1471-4159.1998.70010335.X |
0.451 |
|
| 1996 |
McLoughlin DM, Miller CC. The intracellular cytoplasmic domain of the Alzheimer's disease amyloid precursor protein interacts with phosphotyrosine-binding domain proteins in the yeast two-hybrid system. Febs Letters. 397: 197-200. PMID 8955346 DOI: 10.1016/S0014-5793(96)01128-3 |
0.49 |
|
| Show low-probability matches. |